Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emricasan in Clinical Islet Transplantation
NCT01653899Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Jun 2012
- Primary completion
- Jun 2016
- Countries
- 1
01
Overview
A Phase 2 trial of emricasan in type 1 diabetes mellitus (T1D), sponsored by University of Alberta. Started Jun 2012; status: completed.
02
Drugs
emricasan
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01653899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01653899.